Literature DB >> 11935317

Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk.

Bao-li Chang1, Siqun L Zheng, Gregory A Hawkins, Sarah D Isaacs, Kathy E Wiley, Aubrey Turner, John D Carpten, Eugene R Bleecker, Patrick C Walsh, Jeffrey M Trent, Deborah A Meyers, William B Isaacs, Jianfeng Xu.   

Abstract

Androgen receptor (AR) has long been hypothesized to play an important role in prostate cancer etiology. Two trinucleotide repeat polymorphisms (CAG and GGC repeats in exon 1 of the AR gene) have been investigated as risk factors for prostate cancer in several studies. However, the results are inconclusive, probably because of the variations of study designs, characteristics of study samples, and choices of analytical methods. In this study, we evaluated evidence for linkage and association between the two AR repeats and prostate cancer by using the following comprehensive approaches: (1) a combination of linkage and association studies, (2) a test for linkage by parametric analysis and the male-limited X-linked transmission/disequilibrium test (XLRC-TDT), (3) a test for association by using both population-based and family-based tests, and (4) a study of both hereditary and sporadic cases. A positive but weak linkage score (HLOD=0.49, P=0.12) was identified in the AR region by parametric analysis; however, stronger evidence for linkage in the region, especially at the GGC locus, was observed in the subset of families whose proband had < or = 16 GGC repeats (HLOD=0.70, P=0.07) or by using XLRC-TDT ( z'=2.65, P=0.008). Significantly increased frequencies of the < or = 16 GGC repeat alleles in 159 independent hereditary cases (71%) and 245 sporadic cases (68%) cases compared with 211 controls (59%) suggested that GGC repeats were associated with prostate cancer ( P=0.02). Evidence for the association between the < or = 16 GGC repeats and prostate cancer risk was stronger with XLRC-TDT ( z'=2.66, P=0.007). No evidence for association between the CAG repeats and prostate cancer risk was observed. The consistent results from both linkage and association studies strongly implicate the GGC repeats in the AR as a prostate cancer susceptibility gene. Further studies on this polymorphism in other independent data sets and functional analysis of the GGC repeat length on AR activity are warranted.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11935317     DOI: 10.1007/s00439-001-0662-6

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  16 in total

1.  South Indian men with reduced CAG repeat length in the androgen receptor gene have an increased risk of prostate cancer.

Authors:  Vijayalakshmi Krishnaswamy; Thangaraj Kumarasamy; Vettriselvi Venkatesan; Sunil Shroff; Vikram R Jayanth; Solomon F D Paul
Journal:  J Hum Genet       Date:  2006-01-26       Impact factor: 3.172

2.  Influence of androgen receptor repeat polymorphisms on personality traits in men.

Authors:  Lars Westberg; Susanne Henningsson; Mikael Landén; Kristina Annerbrink; Jonas Melke; Staffan Nilsson; Roland Rosmond; Göran Holm; Henrik Anckarsäter; Elias Eriksson
Journal:  J Psychiatry Neurosci       Date:  2009-05       Impact factor: 6.186

3.  Androgen receptor CAG and GGC polymorphisms in Mediterraneans: repeat dynamics and population relationships.

Authors:  Esther Esteban; Natalia Rodon; Marc Via; Emili Gonzalez-Perez; Josep Santamaria; Jean-Michel Dugoujon; Farha El Chennawi; Mohamed Melhaoui; Mohamed Cherkaoui; Giuseppe Vona; Nourdin Harich; Pedro Moral
Journal:  J Hum Genet       Date:  2005-12-20       Impact factor: 3.172

4.  The CAG repeat polymorphism of androgen receptor gene and prostate cancer: a meta-analysis.

Authors:  Mingliang Gu; Xiaoqun Dong; Xuezhi Zhang; Wenquan Niu
Journal:  Mol Biol Rep       Date:  2011-06-12       Impact factor: 2.316

5.  Direct detection of the AR-E211 G > A gene polymorphism from blood and tissue samples without DNA isolation.

Authors:  Silvie Reptova; Katerina Smesny Trtkova; Zdenek Kolar
Journal:  Pathol Oncol Res       Date:  2014-02-01       Impact factor: 3.201

Review 6.  Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.

Authors:  S Salvi; V Conteduca; G Gurioli; D Calistri; V Casadio; U De Giorgi
Journal:  Mol Diagn Ther       Date:  2016-02       Impact factor: 4.074

Review 7.  Shorter GGN Repeats in Androgen Receptor Gene Would Not Increase the Risk of Prostate Cancer.

Authors:  Jiatong Li; Feifan Xiao; Yuening Zhang; Aihua Lan; Qian Song; Ruoheng Zhang; Kailong Gu; Ping Chen; Zhuo Li; Xinhua Zhang; Xiaoli Yang
Journal:  Technol Cancer Res Treat       Date:  2016-10-17

8.  Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia.

Authors:  Axel M Hillmer; Sandra Hanneken; Sibylle Ritzmann; Tim Becker; Jan Freudenberg; Felix F Brockschmidt; Antonia Flaquer; Yun Freudenberg-Hua; Rami Abou Jamra; Christine Metzen; Uwe Heyn; Nadine Schweiger; Regina C Betz; Bettina Blaumeiser; Jochen Hampe; Stefan Schreiber; Thomas G Schulze; Hans Christian Hennies; Johannes Schumacher; Peter Propping; Thomas Ruzicka; Sven Cichon; Thomas F Wienker; Roland Kruse; Markus M Nothen
Journal:  Am J Hum Genet       Date:  2005-05-18       Impact factor: 11.025

9.  Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

Authors:  Jie Li; Emma Mercer; Xin Gou; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

Review 10.  Sex steroid-related candidate genes in psychiatric disorders.

Authors:  Lars Westberg; Elias Eriksson
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.